Dr. Susannah Claire Brock Cornes, MD

Dr. Cornes practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Cornes' NPI, 1487748091, was assigned on October 3, 2006. Dr. Cornes graduated from UCSF School of Medicine in 2003. Dr. Cornes holds California license A91846.

Dr. Cornes' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Cornes' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Cornes is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Cornes to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cornes practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cornes' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cornes is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Cornes is licensed in California.

Dmand AI lists epilepsy, seizures and vertigo among the conditions Dr. Cornes treats.

CMS data shows 434 Medicare services from Dr. Cornes across 8 procedure codes in 2024, for 212 Medicare patients. Medicare paid $48,841 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Cornes in 2024. The largest group is under 65, with 78 patients. 68% of them have high cholesterol, and 66% have high blood pressure. 53% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cornes' median patient age at 46, with 46% women.

In 2024, Dr. Cornes wrote 1,444 Medicare Part D claims for 160 patients. 80% of them were for generic drugs. CMS names the drug for 1,342 of them, across 32 drugs with 11 or more claims each, at $573,930 in total drug cost. In 2023, CMS named 1,096 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cornes for performance year 2024, reported as part of a group. Dr. Cornes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cornes as offering telehealth.

Dmand AI links 24 papers to Dr. Cornes, published from 2008 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Electroencephalography, Drug Resistant Epilepsy and Seizures. Dr. Cornes has published most often in Neurology. Dr. Cornes' most frequent co-authors are Edward F. Chang, MD, Dario J. Englot, MD, PhD and Sheryl R. Haut, MD.

Dmand AI links Dr. Cornes to 1 clinical trial. Conditions studied include Seizures and Epilepsy.

CMS Open Payments shows 2 general payments to Dr. Cornes from 2 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Neuropace, Inc. paid the most, $38.

Dmand AI lists 1 award for Dr. Cornes, most recently CMS Stage 1 EHR in 2013.

Dr. Cornes graduated from UCSF School of Medicine in 2003.

Dr. Cornes is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.